Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.
作者信息
Cholankeril George, Al-Hillan Alsadiq, Tarlow Brandon, Abrams Daniela, Jacobs Jake S, Flores Norma P, Rana Abbas, Kanwal Fasiha, Goss John A
机构信息
Section of Gastroenterology and Hepatology, Department of Medicine Baylor College of Medicine Houston TX Liver Center, Division of Abdominal Transplantation, Michael E. DeBakey Department of General Surgery Baylor College of Medicine Houston TX Division of Gastroenterology and Hepatology Stanford University School of Medicine Stanford CA Section of General Medicine Baylor College of Medicine Houston TX Center for Innovations in Quality, Effectiveness and Safety Michael E. DeBakey Veterans Affairs Medical Center Houston TX.
出版信息
Liver Transpl. 2022 Jan;28(1):123-126. doi: 10.1002/lt.26351. Epub 2021 Dec 3.
Abstract
摘要
相似文献
1
Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.肝移植受者对SARS-CoV-2信使核糖核酸疫苗血清学无应答相关的临床因素
Liver Transpl. 2022 Jan;28(1):123-126. doi: 10.1002/lt.26351. Epub 2021 Dec 3.
2
Coronavirus Disease 2019 Messenger RNA Vaccine and Liver Transplant Recipients.2019冠状病毒病信使核糖核酸疫苗与肝移植受者
Liver Transpl. 2022 Jan;28(1):140. doi: 10.1002/lt.26295. Epub 2021 Sep 25.
3
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.肝移植受者中 2 剂 BNT162b2 mRNA 疫苗的免疫原性和不良反应。
Liver Transpl. 2022 Feb;28(2):215-223. doi: 10.1002/lt.26366. Epub 2021 Dec 8.
4
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
5
Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.mRNA SARS-CoV-2 疫苗在肺移植受者中的疗效和安全性。
J Infect Chemother. 2022 Aug;28(8):1153-1158. doi: 10.1016/j.jiac.2022.04.019. Epub 2022 May 17.
6
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients.肝移植受者接种 2 剂 BNT162b2 mRNA COVID-19 疫苗后的体液免疫反应。
Clin Gastroenterol Hepatol. 2022 Jul;20(7):1534-1541.e4. doi: 10.1016/j.cgh.2022.01.012. Epub 2022 Jan 20.
7
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients.肾移植受者接种第三剂 mRNA SARS-CoV-2 疫苗后对 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株的中和抗体反应。
Am J Transplant. 2022 Jul;22(7):1873-1883. doi: 10.1111/ajt.17054. Epub 2022 Apr 18.
8
The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.SARS-CoV-2 疫苗的种类会影响肾移植受者的血清学反应。
Clin Transplant. 2022 Apr;36(4):e14585. doi: 10.1111/ctr.14585. Epub 2022 Jan 18.
9
Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient.一名肝移植受者接种基于mRNA的SARS-CoV-2疫苗后的肝损伤
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101743. doi: 10.1016/j.clinre.2021.101743. Epub 2021 Jun 16.
10
Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。
Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.
引用本文的文献
1
Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review.提高实体器官移植受者中SARS-CoV-2疫苗免疫原性的措施：一项叙述性综述
Vaccines (Basel). 2023 Nov 25;11(12):1755. doi: 10.3390/vaccines11121755.
2
Effects of Anti-COVID-19 Vaccination and Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab in Kidney and Liver Transplant Recipients.肾和肝移植受者中抗 COVID-19 疫苗接种和替沙格韦单抗-西加韦单抗预先暴露预防的效果。
Medicina (Kaunas). 2023 Nov 30;59(12):2101. doi: 10.3390/medicina59122101.
3
Seroconversion and safety of Covid-19 vaccines in pa-tients with chronic liver disease and liver transplant: A systematic review.新型冠状病毒肺炎疫苗在慢性肝病和肝移植患者中的血清学转换及安全性：一项系统评价。
Qatar Med J. 2023 Dec 12;2023(3):21. doi: 10.5339/qmj.2023.21. eCollection 2023.
4
Factors influencing immunogenicity and safety of SARS-CoV-2 vaccine in liver transplantation recipients: a systematic review and meta-analysis.影响肝移植受者 SARS-CoV-2 疫苗免疫原性和安全性的因素：系统评价和荟萃分析。
Front Immunol. 2023 Sep 5;14:1145081. doi: 10.3389/fimmu.2023.1145081. eCollection 2023.
5
Antibody titer after administration of mRNA-based vaccine against severe acute respiratory syndrome coronavirus 2 in liver transplant recipients.肝移植受者接种严重急性呼吸综合征冠状病毒2 mRNA疫苗后的抗体滴度
Ann Gastroenterol Surg. 2023 Apr 19;7(5):800-807. doi: 10.1002/ags3.12677. eCollection 2023 Sep.
6
Adjustment of Immunosuppressants to Facilitate Anti-COVID-19 Antibody Production after mRNA Vaccination in Liver Transplant Recipients.调整免疫抑制剂以促进肝移植受者 mRNA 疫苗接种后抗 COVID-19 抗体的产生。
Viruses. 2023 Mar 4;15(3):678. doi: 10.3390/v15030678.
7
Durability of Immune Response after Application of a Third Dose of SARS-CoV-2 Vaccination in Liver Transplant Recipients.肝移植受者接种第三剂严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗后的免疫反应持久性
Vaccines (Basel). 2023 Mar 2;11(3):572. doi: 10.3390/vaccines11030572.
8
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的免疫原性：系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.
9
Determinants of Antibody Response to SARS-CoV-2 Vaccines in Liver Transplant Recipients: The Role of Immunosuppression Reduction.肝移植受者对SARS-CoV-2疫苗抗体反应的决定因素：降低免疫抑制的作用。
Vaccines (Basel). 2022 Oct 29;10(11):1827. doi: 10.3390/vaccines10111827.
10
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis.慢性肝病患者和肝移植受者的 COVID-19 疫苗免疫原性：一项荟萃分析。
Clin Mol Hepatol. 2022 Oct;28(4):890-911. doi: 10.3350/cmh.2022.0087. Epub 2022 Jun 3.
Zotero 插件